SIXFOLD BIOSCIENCE

sixfold-bioscience-logo

Sixfold Bioscience engineers programmable oligonucleotide delivery systems are able to deliver RNA exclusively to diseased cells. It is based in London.

#SimilarOrganizations #People #Financial #Event #Website #More

SIXFOLD BIOSCIENCE

Social Links:

Industry:
Biotechnology Medical Nanotechnology Therapeutics

Founded:
2018-01-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.sixfold.bio

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
10.62 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Google Apps For Business GoDaddy DNS Typekit


Similar Organizations

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

privo-technologies-logo

Privo Technologies

Privo Technologies is a development-stage biotechnology company located just outside Boston, MA.

translate-bio-logo

Translate Bio

Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.

ribbon-biolabs-logo

Ribbon Biolabs

Ribbon Biolabs defines new standards for molecular biology by applying innovative methods for DNA synthesis.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

slingshot-biosciences-logo

Slingshot Biosciences

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

theolytics-logo

Theolytics

Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.

Current Employees Featured

george-foot_image

George Foot
George Foot Co-Founder & Co-CEO @ Sixfold Bioscience
Co-Founder & Co-CEO
2017-03-01

anna-perdrix-rosell_image

Anna Perdrix Rosell
Anna Perdrix Rosell Co-Founder & Co-CEO @ Sixfold Bioscience
Co-Founder & Co-CEO
2017-03-01

Founder


anna-perdrix-rosell_image

Anna Perdrix Rosell

george-foot_image

George Foot

zuzanna-brzosko_image

Zuzanna Brzosko

Investors List

lombardstreet-io_image

Lombardstreet Ventures

Lombardstreet Ventures investment in Seed Round - Sixfold Bioscience

cantos-ventures_image

Cantos

Cantos investment in Seed Round - Sixfold Bioscience

bossanova-investimentos_image

Bossanova Investimentos

Bossanova Investimentos investment in Seed Round - Sixfold Bioscience

pi-2_image

Pi Campus

Pi Campus investment in Seed Round - Sixfold Bioscience

lombardstreet-io_image

Lombardstreet Ventures

Lombardstreet Ventures investment in Pre Seed Round - Sixfold Bioscience

pi-2_image

Pi Campus

Pi Campus investment in Pre Seed Round - Sixfold Bioscience

y-combinator_image

Y Combinator

Y Combinator investment in Pre Seed Round - Sixfold Bioscience

Newest Events participated

y-combinator-winter-2018-demo-day_event_image Participated in Y Combinator Winter 2018 Demo Day on 2018-03-19 as exhibitor

Official Site Inspections

http://www.sixfold.bio Semrush global rank: 5.61 M Semrush visits lastest month: 1.51 K

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 75.2.70.75
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Sixfold Bioscience"

Sixfold

RNA, evolved. Weโ€™re solving delivery to build the future of RNA therapies. Inspired by evolution, perfected with AI. Meet Mergo®See details»

Sixfold Bioscience - Crunchbase Company Profile & Funding

Sixfold Bioscience closed its last funding round on Dec 2, 2021 from a Grant round. Who are Sixfold Bioscience 's competitors? Alternatives and possible competitors to Sixfold Bioscience โ€ฆSee details»

Sixfold

Feb 27, 2025 Funding will support the advancement of Sixfoldโ€™s Mergo RNA therapeutics delivery platform, enabling delivery of mRNA and siRNA to tissues beyond the liver Sixfold โ€ฆSee details»

Sixfold Bioscience: Delivering RNA therapies. - Y Combinator

Dec 2, 2021 Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression. Latest โ€ฆSee details»

Sixfold Bioscience - PitchBook

Sixfold Bioscience General Information Description. Developer of a ribonucleic acid delivery platform designed to conduct cell and gene therapeutics. The company's platform utilizes โ€ฆSee details»

Destination.bio - Sixfold Bioscience

Sixfold Bioscience is the coordinator organisation for the DESTINATION project, and will manage the overall consortium collaboration, finances and communication. During DESTINATION, โ€ฆSee details»

Sixfold Bioscience Announces Formation of Scientific Advisory Board

Aug 9, 2023 Sixfold Bioscience, a leading AI-enabled RNA delivery company that leverages the bodyโ€™s evolved delivery pathways, is pleased to announce the formatio Sixfold Bioscience โ€ฆSee details»

Sixfold Bioscience Company Information - Funding, Investors, and โ€ฆ

Sixfold Bioscience focuses on advancing RNA therapies, placing it at the forefront of biotech innovation in medical treatments. Based in London, the company operates on a B2B model, โ€ฆSee details»

Sixfold Bioscience - Forbes

Sixfold Bioscience on the 2018 30 Under 30 - Europe - Science & Healthcare - Getting a drug to the right part of the body is a persistent problem in medicine.See details»

Sixfold Bioscience - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Sixfold Bioscience . 1: โ€ฆSee details»

Sixfold Bioscience - London, United Kingdom - bionity.com

Dec 7, 2021 Sixfold Bioscience is a venture-backed preclinical-stage biotechnology company, founded in 2017, based at the Translation & Innovation Hub in White City, London. Sixfold โ€ฆSee details»

RNA Architects. Why we invested in Sixfold Bioscience - Medium

Dec 14, 2021 Enter London-based Sixfold Bioscience, Co-Founded by Anna Perdrix-Rosell and George Foot. Sixfold is building Mergo ® , a computationally-integrated platform that โ€ฆSee details»

Sixfold Bioscience completes $10.5M USD (£7.8M GBP) seed โ€ฆ

London, UK, 02 Dec 2021: Sixfold Bioscience (Sixfold), a company harnessing computation and advanced chemistry to design RNA therapeutic delivery systems, today announced it has โ€ฆSee details»

Sixfold Bioscience | EU-Startups

Sixfold Bioscience is an award-winning, Y Combinator and venture-backed, preclinical-stage biotech based in London. Founded by experienced researchers from Cambridge Univeristy โ€ฆSee details»

Sixfold raises $10.5M to advance targeted mRNA therapies

Jul 23, 2023 Sixfold Bioscience is a venture-backed preclinical-stage biotechnology company, founded in 2017, based at the Translation & Innovation Hub in White City, London. Sixfold โ€ฆSee details»

Sixfold Bioscience | CipherBio

Explore Sixfold Bioscience's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»

Sixfold Bioscience - Cambridge Judge Business School

Sixfold Bioscience is a biotech startup developing drug delivery nanotools for cancer. Cancers are complex diseases driven by multiple genetic pathways but the currently available therapeutics โ€ฆSee details»

Sixfold Bioscience Completes $10.5M USD (£7.8M GBP) Seed โ€ฆ

Dec 2, 2021 Sixfold Bioscience, a company designing RNA therapeutic delivery systems, announced it has raised $10.5 million USD in its seed funding round. Sixfold Bioscience โ€ฆSee details»

Sixfold

Sixfold Bioscience Ltd. Sixfold Bioscience is a venture-backed preclinical-stage biotechnology company based at the Innovation and Translation Hub in White City, London. Sixfold develops โ€ฆSee details»

AI-guided precision parenteral nutrition for neonatal intensive care ...

2 days ago In Proc. Twenty-Sixth International Joint Conference on Artificial Intelligence (IJCAI-17) (ed Sierra, C.) 1753โ€“1759 (International Joint Conferences on Artificial Intelligence โ€ฆSee details»

linkstock.net © 2022. All rights reserved